Related references
Note: Only part of the references are listed.Adverse histology, homozygous loss ofCDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma
Chen Yang et al.
MODERN PATHOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
CDKN2A-Mutated Pancreatic Ductal Organoids from Induced Pluripotent Stem Cells to Model a Cancer Predisposition Syndrome
Jessica Merkle et al.
CANCERS (2021)
lncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2
Sen Hong et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes
Kai Wang et al.
BRITISH JOURNAL OF CANCER (2020)
Baicalein suppresses the proliferation and invasiveness of colorectal cancer cells by inhibiting Snail-induced epithelial-mesenchymal transition
Qiongyao Zeng et al.
MOLECULAR MEDICINE REPORTS (2020)
E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
Michele Sommariva et al.
CELLS (2020)
EMT Factors and Metabolic Pathways in Cancer
Ilias Georgakopoulos-Soares et al.
FRONTIERS IN ONCOLOGY (2020)
Comprehensive review of targeted therapy for colorectal cancer
Yuan-Hong Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
EMT and Cancer: More Than Meets the Eye
Rik Derynck et al.
DEVELOPMENTAL CELL (2019)
Context-dependent EMT programs in cancer metastasis
Nicole M. Aiello et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer
Qingyuan Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
Ting Li et al.
MOLECULAR CANCER (2019)
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
NaNa Keum et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
Chin-Yap Loh et al.
CELLS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
EMT Transition States during Tumor Progression and Metastasis
Ievgenia Pastushenko et al.
TRENDS IN CELL BIOLOGY (2019)
LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1
Xinke Wang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis
Nam Q. Bui et al.
CLINICAL SARCOMA RESEARCH (2019)
Concise update on colorectal cancer epidemiology
Camilla Mattiuzzi et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
Q. Tu et al.
ONCOGENE (2018)
LncRNA HIF1A-AS2 positively affects the progression and EMT formation of colorectal cancer through regulating miR-129-5p and DNMT3A
Jinguan Lin et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation
Heike Pfeifer et al.
BLOOD (2018)
Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation
Hanlin Zeng et al.
CANCER CELL (2018)
LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer
T. Boulding et al.
SCIENTIFIC REPORTS (2018)
CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma
William S. Chen et al.
FRONTIERS IN ONCOLOGY (2018)
Drug resistance and new therapies in colorectal cancer
Kevin Van der Jeught et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells
Eun-Hui Jeong et al.
CELLULAR ONCOLOGY (2018)
Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer
S. H-S Lim et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis
X. Xing et al.
BRITISH JOURNAL OF CANCER (2013)
Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity to Chemoradiotherapy in Non-Small Cell Lung Cancer
Yasushi Shintani et al.
ANNALS OF THORACIC SURGERY (2011)
The Search for Unaffected Individuals with Lynch Syndrome: Do the Ends Justify the Means?
Heather Hampel et al.
CANCER PREVENTION RESEARCH (2011)
Colorectal cancers with both p16 and p14 methylation show invasive characteristics
K Hibi et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
Share Paper
